Viimane versioon :
03/05/2024
Infostab
Ingredientide nimekiri
Nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
Uurimisrühmad
Valistab
Plakat
Sidemed
Sponsorid
Autor
Kasutusjuhend
Ajakiri
Uurimisrühmad - Genentech, Inc
Genentech, Inc
San Francisco
sreedhaa@gene.com
Viited
(5)
1
Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags
Hui A, Yin J, Liu W, Zheng K. (zheng.kai@gene.com)
Int J Pharm Compound -
2021
- ;25,3:246-257
2
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A. (sreedhaa@gene.com))
J Pharm Sci -
2012
- ; DOI 10.1002 / jps.23403
3
in vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz, Y.K. , Joyce, M., Lam, X. (lentz.yvonne@gene.com)
AAPS Pharm Sci -
2011
- ; 15, 2 : 264-272.
4
In vitro stability and compatibility of tenecteplase in central venous access devices.
Lentz Y.K, Joyce M, Lam X. ()
Hemodial Int -
2011
- ; 15, 2 : 364-272.
5
Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.
Lam XM, Ward CA, de C du M?e CPR. ()
Am J Health-Syst Pharm -
1995
- ; 52: 1904-1909.
Molekulid uuritud
(13)
Alteplase
Atezolizumab
Dobutamine hydrochloride
Dopamine hydrochloride
Heparin sodium
Lidocaine hydrochloride
Metoprolol tartrate
Morphine sulfate
Nitroglycerin
Pertuzumab
Propranolol hydrochloride
Tenecteplase
Trastuzumab
Mentions Légales
